Early and extensive CD55 loss from red blood cells supports a causal role in malarial anaemia

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Gwamaka, Moses ^a,b,c   Fried, Michal ^a,d,e   Domingo, Gonzalo ^a,f   Duffy, Patrick E ^a,d,e  

^a Muheza Designated District Hospital   (Tanzania)

^b SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; HEMOGLOBIN; CD59 PROTEIN, HUMAN;

AGE DISTRIBUTION; ANEMIA; ARTICLE; BLOOD SAMPLING; CELL AGING; CHILD; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOFLUOROMETRY; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA ANEMIA; MALE; MEAN CORPUSCULAR VOLUME; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TANZANIA; BLOOD; ERYTHROCYTE LIFESPAN; IMMUNOLOGY; INFANT; MALARIA FALCIPARUM; METABOLISM; PARASITE LOAD; PARASITEMIA; PARASITOLOGY; PATHOGENICITY;

ANEMIA; ANTIGENS, CD55; ANTIGENS, CD59; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ERYTHROCYTE AGING; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITE LOAD; PARASITEMIA; PLASMODIUM FALCIPARUM; TANZANIA;

EID: 84855169690     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-386     Document Type: Article

References (31)

1. Anemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected RBC. Jakeman GN, Saul A, Hogarth WL, Collins WE, Parasitology 1999 119 127 133 10.1017/S0031182099004564 10466119 (Pubitemid 29381129)
2. Factors contributing to anemia after uncomplicated falciparum malaria. Price RN, Simpson JA, Nosten F, Luxembuger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ, Am J Trop Med Hyg 2001 65 614 622 11716124 (Pubitemid 33134602)
3. Blood and bone marrow changes in malaria. Wickramasinghe SN, Abdalla SH, Baillieres Best Pract Res Clin Haemato 2000 13 277 99 10.1053/beha.1999.0072
4. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA, Blood 2000 95 1481 1486 10666228 (Pubitemid 30099864)
5. Complement-mediated clearance of RBC: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC, Blood 2002 100 4544 4549 10.1182/blood-2002-06-1875 12393518 (Pubitemid 35429696)
6. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Holt DS, Botto M, Bygrave AE, Hanna SM, Walport MJ, Morgan BP, Blood 2001 98 442 449 10.1182/blood.V98.2.442 11435315
7. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Miwa T, Maldonado MA, Zhou L, Sun X, Luo HY, Cai D, Werth VP, Madaio MP, Eisenberg RA, Song WC, Am J Pathol 2002 1 1077 1086 (Pubitemid 34988395)
8. Loss of complement receptor type 1 (CR1) on ageing of RBC. Studies of proteolytic release of the receptor. Ripoche J, Sim RB, Biochem J 1986 235 815 821 2944510 (Pubitemid 16071993)
9. Reduced CR1 expression on aged human RBC: immuno-electron microscopic and functional analysis. Fishelson Z, Marikovsky Y, Mech Ageing Dev 1993 72 25 35 10.1016/0047-6374(93)90128-E 8114517
10. Cellular and molecular mechanisms of senescent RBC phagocytosis by macrophages. A review. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, Montreuil J, Biochimie 1998 80 173 195 10.1016/S0300-9084(98)80024-2 9587675 (Pubitemid 28185056)
11. The mechanism of loss of CR1 during maturation of RBC is different between factor I deficient patients and healthy donors. Miot S, Marfurt J, Lach-Trifilieff E, Gonzalez-Rubio C, Lopez-Trascasa M, Sadallah S, Schifferli JA, Blood Cells Mol Dis 2002 29 200 212 10.1006/bcmd.2002.0559 12490287
12. Human erythrocyte fraction in "Percoll" density gradients. Rennie CM, Thompson S, Parker AC, Maddy A, Clin Chim Acta 1979 98 119 125 10.1016/0009-8981(79)90172-4 498523 (Pubitemid 10249618)
13. Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Omodeo-Salè F, Motti A, Basilico N, Parapini S, Olliaro P, Taramelli D, Blood 2003 102 705 711 10.1182/blood-2002-08-2437 12649148 (Pubitemid 36841995)
14. The anemia of P. falciparum malaria. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M, Br J Haematol 1980 46 171 183 10.1111/j.1365-2141. 1980.tb05956.x 7000157
15. Clinical utility of fractionating erythrocytes into "Percll" density gradients. Mosca A, Paleari R, Modenese A, Rossini S, Parma R, Rocco C, Russo V, Caramenti G, Paderi ML, Galanello R, Adv Exp Med Biol 1991 307 227 238 1666816
16. Swine erythrocyte fractionation in Percoll density gradients. Asano R, Murasugi E, Hokari S, Zentralbl Veterinarmed A 1993 40 641 645 8135069
17. Ionic calcium content of light dense human red cells separated by Percoll density gradients. Romero PJ, Romero EA, Winkler MD, Biochim Biophys Acta 1997 1323 23 28 10.1016/S0005-2736(96)00141-1 9030209 (Pubitemid 27051430)
18. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization. Risso A, Turello M, Biffoni F, Antonutto G, Blood Cells, Molecules, and Diseases 2007 38 83 92 10.1016/j.bcmd.2006.10.161 17188915 (Pubitemid 46186061)
19. Erythrocyte vesiculation: a self-protective mechanism? Willekens FL, Werre JM, Groenen-Döpp YA, Roerdinkholder-Stoelwinder B, de Pauw B, Bosman GJ, Br J Haematol 2008 141 549 556 10.1111/j.1365-2141.2008.07055.x 18419623 (Pubitemid 351550554)
20. Catabolism of the human RBC C3b/C4b receptor (CR1, CD35): Vesiculation and/or proteolysis? Dervillez X, Oudin S, Libyh MT, Tabary T, Reveil B, Philbert F, Bougy F, Pluot M, Cohen JH, Immunopharmacology 1997 38 129 140 10.1016/S0162-3109(97)00066-0 9476124 (Pubitemid 28049973)
21. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. Craig ML, Waitumbi JN, Taylor RP, J Immunol 2005 174 3059 3066 15728520 (Pubitemid 40279727)
22. Immune complex levels in children with severe Plasmodium falciparum malaria. Mibei EK, Orago AS, Stoute JA, Am J Trop Med Hyg 2005 72 593 599 15891134
23. Loss of red blood cell-complement regulatory proteins and increased levels of circulating immune complexes are associated with severe malarial anemia. Stoute JA, Odindo AO, Owuor BO, Mibei EK, Opollo MO, Waitumbi JN, J Infect Dis 2003 187 522 5225 10.1086/367712 12552440 (Pubitemid 36184597)
24. Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Owuor BO, Odhiambo CO, Otieno WO, Adhiambo C, Makawiti DW, Stoute JA, Mol Med 2008 14 89 97 18317566 (Pubitemid 351481839)
25. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia. Odhiambo CO, Otieno W, Adhiambo C, Odera MM, Stoute JA, BMC Med 2008 6 23 10.1186/1741-7015-6-23 18717995
26. Complement binding to RBC is associated with macrophage activation and reduced haemoglobin in Plasmodium falciparum malaria. Goka BQ, Kwarko H, Kurtzhals JA, Gyan B, Ofori-Adjei E, Ohene SA, Hviid L, Akanmori BD, Neequaye J, Trans R Soc Trop Med Hyg 2001 95 545 549 10.1016/S0035-9203(01)90036-7 11706671 (Pubitemid 34947415)
27. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria. Jhaveri KN, Ghosh K, Mohanty D, Parmar BD, Surati RR, Camoens HM, Joshi SH, Lyer YS, Desai A, Badakere SS, Natl Med J India 1997 10 5 7 9069696 (Pubitemid 127606401)
28. Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected RBC. Wiesner J, Jomaa H, Wilhelm M, Tony HP, Kremsner PG, Horrocks P, Lanzer M, Eur J Immunol 1997 27 2708 2713 10.1002/eji.1830271034 9368630 (Pubitemid 27453864)
29. Characterization of the active sites in decay-accelerating factor. Kuttner-Kondo LA, Mitchell L, Houracade DE, Medof ME, J Immunol 2001 167 2164 2171 11490001 (Pubitemid 32747526)
30. Structure and function of decay accelerating factor CD55. Nicholson-Weller A, Wang CE, J Lab Clin Med 1994 123 485 491 7511675 (Pubitemid 2083544)
31. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. Rollins SA, Zhao J, Ninomiwa H, Sims PJ, J Immunology 1991 146 2345 2351